CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $48.1 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 60 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.86 per share.

The biopharmaceutical company posted revenue of $189.4 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $170.1 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News